A dynamic, highly specialized molecular laboratory
CYNOGEN is a US laboratory based in California focused on the detection, prognosis and prediction of response to therapy in certain cancers. The company utilizes a combination of proprietary FDA-approved molecular testing and other diagnostic testing platforms.
Our area of particular focus is the early detection of chromosomal changes, through Fluorescence in situ Hybridization (FISH) technology, that may signal cancer and the detection of gene rearrangements that identify patients most likely to respond to targeted therapies.
We strive to provide information to aid physicians in the management of their patients with cancer.